Intervention not reported
Budesonide (1 RCT; 43 participants) · surgically induced remission in Crohn's disease
The intervention showed no clear difference in budesonide (1 RCT; 43 participants) (low certainty).
1 finding from 1 review
Intervention not reported
5‐ASA (9 RCTs; 542 participants) · surgically induced remission in Crohn's disease
The intervention probably leads to lower 5‐ASA (9 RCTs; 542 participants) (moderate certainty).
1 finding from 1 review
Intervention not reported
Purine analogues (6 RCTs; 316 participants) · surgically induced remission in Crohn's disease
The intervention showed no clear difference in purine analogues (6 RCTs; 316 participants) (low certainty).
1 finding from 1 review
Intervention not reported
Failure rate of post‐pyloric placement of the enteral feeding tube assessed by abdominal radiograph Radiographic assessment of successful tube placement · patients needing post‐pyloric placement of naso‐enteral feeding tubes
It is very uncertain whether the intervention changes failure rate of post‐pyloric placement of the enteral feeding tube… (very low certainty).
1 finding from 1 review
Rate of admission during ED stay · patients with vomiting related to acute gastroenteritis with mild to moderate dehydration
Oral ondansetron (weight based) probably leads to lower rate of admission during ED stay compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events · patients with vomiting related to acute gastroenteritis with mild to moderate dehydration
1 finding from 1 review
Rate of admission 72 hrs · patients with vomiting related to acute gastroenteritis with mild to moderate dehydration
Oral ondansetron (weight based) showed no clear difference in rate of admission 72 hrs compared with placebo (low certainty).
2 findings from 1 review
Time to cessation of vomiting · patients with vomiting related to acute gastroenteritis with mild to moderate dehydration
1 finding from 1 review
Rate of intravenous rehydration during ED stay · patients with vomiting related to acute gastroenteritis with mild to moderate dehydration
Oral ondansetron (weight based) probably leads to lower rate of intravenous rehydration during ED stay compared with placebo (moderate certainty).
1 finding from 1 review
Rate of intravenous rehydration up to 72 hrs following discharge from ED (best ‐ worst scenario) · patients with vomiting related to acute gastroenteritis with mild to moderate dehydration
Oral ondansetron (weight based) may leads to lower rate of intravenous rehydration up to 72 hrs following discharge… compared with placebo (low certainty).
1 finding from 1 review
Rate of intravenous rehydration up to 72 hrs following discharge from ED (worst ‐ best scenario) · patients with vomiting related to acute gastroenteritis with mild to moderate dehydration
Oral ondansetron (weight based) may leads to lower rate of intravenous rehydration up to 72 hrs following discharge… compared with placebo (low certainty).
1 finding from 1 review
Proportion of patients with cessation of vomiting · patients with vomiting related to acute gastroenteritis with mild to moderate dehydration
Oral ondansetron (weight based) probably leads to higher proportion of patients with cessation of vomiting compared with placebo (moderate certainty).
1 finding from 1 review
Revisit rate · patients with vomiting related to acute gastroenteritis with mild to moderate dehydration
Oral ondansetron (weight based) showed no clear difference in revisit rate compared with placebo (low certainty).
1 finding from 1 review